Previous Close | 7.16 |
Open | 7.41 |
Bid | 7.14 x 0 |
Ask | 7.22 x 0 |
Day's Range | 7.12 - 7.43 |
52 Week Range | 5.80 - 10.70 |
Volume | |
Avg. Volume | 60,531 |
Market Cap | 459.091M |
Beta (5Y Monthly) | 1.44 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.57 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jul 22, 2010 |
1y Target Est | N/A |
Year-over-year revenue grows 12%, operating profit up 5%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 28, 2022 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2022. Third Quarter 2022 HighlightsAll comparisons are to the prior year period Revenue increased by 12% to $864.5 million; up 14% on a constant currency basis
Mid-cap healthcare companies have built up a combination of competitive advantages. This article looks at several top stocks in the segment.